Avidity Biosciences in its $12 billion sale to Novartis, and the related spin-off of its early-stage precision cardiology programs
Bain Capital Private Equity in its acquisition of Concert Golf Partners
Azul Systems on a majority strategic investment from Thoma Bravo
